Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Rover Diagnostics logo — Developing fast, high-performance, point-of-care COVID-19 te...

Rover Diagnostics

Developing fast, high-performance, point-of-care COVID-19 test.

Founded 2018 United States Manhattan, United States 14 employees

General Information

Company Name Rover Diagnostics
Founded Year 2018
Location United States Manhattan, United States +2
Employees 14
Social

Get notified when Rover Diagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Rover Diagnostics

Rover Diagnostics is a startup that was founded in 2018 by Samuel Sia and Mark Fasciano in collaboration with Columbia University. The company, based in New York City, is dedicated to developing fast, high-performance, point-of-care COVID-19 tests. This endeavor aligns with Rover's primary mission to address the urgent global need for a cost-effective, highly sensitive, mass-produced point-of-care COVID-19 instrument and test kit system. Notably, Rover is actively participating in the NIH RADx program to expedite the availability and capacity of COVID testing. Although specific details regarding industries, headquarters, last investment, and investors are currently unavailable, Rover Diagnostics' focus on contributing to the battle against the COVID-19 pandemic presents a compelling opportunity for potential investors.

Taxonomy: point-of-care diagnostics, COVID-19 testing, high-performance testing, rapid testing, NIH RADx program, mass production, sensitive testing, instrumentation, biomedical engineering

No funding data available for Rover Diagnostics yet.

Get notified when Rover Diagnostics raises funding

Rover Diagnostics Alternatives & Competitors

Rover Diagnostics vs
SQI Diagnostics
SQI Diagnostics Canada

Our commitment is to improve lives by leveraging our cutting-edge technology to create innovative di...

Post Ipo Equity
28 employees
Biotechnology
Rover Diagnostics vs
Enviral Tech
Enviral Tech United States

We help increase occupancy in senior care by rebuilding trust. Detect pathogens 5 days before anyone...

Pre Seed
2 employees
Biotechnology, Health Care
Rover Diagnostics vs
MedFlow
MedFlow United States

End-to-end software solution for COVID-19 testing for clinics, laboratories, POC testing, and organi...

14 employees
Health Care, Medical Devices

FAQ About Rover Diagnostics

Developing fast, high-performance, point-of-care COVID-19 test.
Rover Diagnostics was founded in 2018.
Rover Diagnostics is headquartered in Manhattan, United States.
Rover Diagnostics has approximately 14 employees.
Top alternatives and competitors to Rover Diagnostics include SQI Diagnostics, Enviral Tech, MedFlow, My Care Labs, TestNOW. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rover Diagnostics and SQI Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Rover Diagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes